Did Trump Know About Israel's Attack Plans?
Man Claims ICE Raided an Elementary School Graduation. It Was a Total Lie.
One Tweet That Obliterates the Narrative About a Dem Senator's Shambolic Antics at...
Neil Gorsuch Highlights a Glaring Problem With the Court's Ruling in IRS Tax...
Trump Has a Message for Iran Hours After Israel Strikes Nuclear Sites, Military
Stefanik Torches Hochul Over New York's Sanctuary Policies in Fiery Exchange
Iran Responds to Israel's Strike
Is This the Reason Newsom Let LA Burn?
The Wizard and the Goblin
Congress Shouldn’t Crush Farmers in Trump’s Big Beautiful Bill
Illegal Aliens Escaped From a New Jersey ICE Detention Center
Former Prime Minister's Spokesperson Details Why It's So Crucial That Israel Attacked Iran
Reality and Idealism
What’s in Your Bomb Shelter?
California’s Chaos: Time for a Law-and-Order Leader
Tipsheet

'Brutal Day For The NYT': Paper Fact Checked Over Claim About Why Trump Is Pushing HCQ

AP Photo/Bebeto Matthews, File

The New York Times sank to a new low, even for them, publishing a story questioning whether President Trump was promoting hydroxychloroquine as a coronavirus treatment because it benefited him financially. 

Advertisement

The paper highlighted the president’s incredibly small financial stake in the maker of chloroquine.

If hydroxychloroquine becomes an accepted treatment, several pharmaceutical companies stand to profit, including shareholders and senior executives with connections to the president. Mr. Trump himself has a small personal financial interest in Sanofi, the French drugmaker that makes Plaquenil, the brand-name version of hydroxychloroquine. (NYT)

As he said on Tuesday, President Trump is a cheerleader for America. He wants this country to thrive. He wants its citizens to prosper. And he wants this virus to affect as few Americans as possible, which is why he has pushed HCQ so heavily—because thousands of doctors in the U.S. and around the world attest to the fact that it works. We don’t have time to waste in clinical trials right now. The suggestion that he’s pushing it for financial benefit is patently absurd. Fact checkers agreed.  

What's True

U.S. President Donald Trump earns some income from three family trusts that are administered independently by J.P. Morgan, an investment bank and wealth-management firm. These trusts are in part invested in mutual funds that themselves are partially invested in companies that produce hydroxychloroquine.

What's False

Trump’s financial stake in these companies is virtually negligible — contained indirectly via mutual funds — and administered through three family trusts he does not control. As a generic drug, hydroxychloroquine is unlikely to provide any one company with significant profits compared to other proprietary drugs. (Snopes)

Advertisement

Editor's Note: Want to support Townhall so we can keep telling the truth about China and the virus they unleashed on the world? Join Townhall VIP  and use the promo code WUHAN to get 25% off VIP membership!

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement